PepGen Inc.

For the period ended Sep 30, 2025. Filed Nov 12, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 12, 2025

PEPG$4.61+92.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Stockholders’ Equity (Unaudited)

CONDENSED CONSOLIDATED STATEMENTS OFSTOCKHOLDERS’ EQUITY

(IN THOUSANDS, EXCEPT SHARE AMOUNTS)

Common Stock · AdditionalPaid-in · Accumulated OtherComprehensive · Accumulated · TotalStockholders’
	Shares	Amount	Capital	(Loss) Income	Deficit	Equity
Balance as of December 31, 2024	32,619,663	$3	$390,057	$23	$(271,463)	$118,620
Vesting of restricted stock units	101,280	—	—	—	—	—
Stock-based compensation expense	—	—	3,432	—	—	3,432
Unrealized loss on marketable securities	—	—	—	(44)	—	(44)
Cumulative translation adjustment arising during the period	—	—	—	(1)	—	(1)
Net loss	—	—	—	—	(30,202)	(30,202)
Balance as of March 31, 2025	32,720,943	$3	$393,489	$(22)	$(301,665)	$91,805
Issuance of stock under the employee stock purchase plan	78,781	—	98	—	—	98
Stock-based compensation expense	—	—	2,363	—	—	2,363
Unrealized loss on marketable securities	—	—	—	(21)	—	(21)
Net loss	—	—	—	—	(23,087)	(23,087)
Balance as of June 30, 2025	32,799,724	$3	$395,950	$(43)	$(324,752)	$71,158
Issuance of stock in public offering, net of underwriters' fees and issuance costs	35,937,500	4	107,582	—	—	107,586
Exercise of stock options	10,000	—	27	—	—	27
Stock-based compensation expense	—	—	2,377	—	—	2,377
Unrealized gain on marketable securities	—	—	—	18	—	18
Net loss	—	—	—	—	(18,026)	(18,026)
Balance as of September 30, 2025	68,747,224	$7	$505,936	$(25)	$(342,778)	$163,140
Balance as of December 31, 2023	23,823,241	$2	$289,867	$34	$(181,482)	$108,421
Issuance of stock in public offering, net of underwriters' fees and issuance costs	7,530,000	1	76,351	—	—	76,352
Issuance of common stock from ATM Sales Agreement, net of underwriters' fees	1,000,000	—	9,900	—	—	9,900
Exercise of stock options	36,194	—	395	—	—	395
Stock-based compensation expense	—	—	2,022	—	—	2,022
Unrealized loss on marketable securities	—	—	—	(20)	—	(20)
Cumulative translation adjustment arising during the period	—	—	—	(51)	—	(51)
Net loss	—	—	—	—	(18,020)	(18,020)
Balance as of March 31, 2024	32,389,435	$3	$378,535	$(37)	$(199,502)	$178,999
Exercise of stock options	128,354	—	1,403	—	—	1,403
Issuance of stock under the employee stock purchase plan	32,614	—	149	—	—	149
Stock-based compensation expense	—	—	2,862	—	—	2,862
Unrealized loss on marketable securities	—	—	—	(37)	—	(37)
Cumulative translation adjustment arising during the period	—	—	—	(1)	—	(1)
Net loss	—	—	—	—	(28,335)	(28,335)
Balance as of June 30, 2024	32,550,403	$3	$382,949	$(75)	$(227,837)	$155,040
Exercise of stock options	39,299	—	407	—	—	407
Stock-based compensation expense	—	—	3,226	—	—	3,226
Unrealized gain on marketable securities	—	—	—	186	—	186
Cumulative translation adjustment during the period	—	—	—	(20)	—	(20)
Net Loss	—	—	—	—	(21,384)	(21,384)
Balance as of September 30, 2024	32,589,702	$3	$386,582	$91	$(249,221)	$137,455

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.